Hofu, Japan

Hidenori Aoki

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidenori Aoki. Retrieved from https://idiyas.com/inventor/hidenori-aoki-uvexu1f2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hidenori Aoki: Innovator in Staurosporine Derivatives

Introduction

Hidenori Aoki is a notable inventor based in Hofu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of staurosporine derivatives. His work focuses on creating compounds with potential anti-cancer and anti-bacterial properties.

Latest Patents

Hidenori Aoki holds 1 patent for his innovative method titled "Production of staurosporine derivative using acid isomerization." This patent describes a process where staurosporine is acidified to isomerize it into a desired derivative, which is then recovered from the acidified solution. This method has implications for developing new therapeutic agents.

Career Highlights

Aoki is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its advancements in biotechnology and pharmaceuticals. His work at the company has positioned him as a key player in the research and development of novel compounds.

Collaborations

Throughout his career, Hidenori Aoki has collaborated with esteemed colleagues such as Satoru Nagamura and Mitsutaka Kino. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Hidenori Aoki's contributions to the field of staurosporine derivatives highlight his role as an influential inventor in pharmaceutical research. His innovative methods and collaborations continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…